Sionna Therapeutics Inc
(NAS:SION)
$
43.99
+2.35 (+5.64%)
Market Cap: 1.99 Bil
Enterprise Value: 1.78 Bil
PE Ratio: 0
PB Ratio: 6.88
GF Score: 12/100 
Sionna Therapeutics Inc at Citi Global Healthcare Conference Transcript
Dec 04, 2025 / 02:45PM GMT
Release Date Price:
$40.88
(-0.68%)
Geoffrey Meacham;US;Analyst
Citi Investment Research
()-
Welcome to the third day of the Citi Global Healthcare Conference. So my name is Geoff Meacham, the senior biopharma analyst here, and we have Sionna with us on stage. So we have Mike, CEO; Elena, CFO.
Mike Cloonan
Sionna Therapeutics Inc - President, Chief Executive Officer, Director
And Charlotte McKee.
Questions & Answers
Geoffrey Meacham;US;Analyst
Citi Investment Research
()-
Yes. So welcome. I mean maybe just to kick it off, Mike, just give us like the two-minute type of elevator pitch. I mean I know the category, you guys do, too, but I think for those on the webcast, maybe for a bit of a background.
Mike Cloonan
Sionna Therapeutics Inc - President, Chief Executive Officer, Director
Yes, happy to, Geoff. And first, thanks for having us. Great to see you, and thanks for Citi for inviting us today. So Sionna, we are focused on cystic
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers